150 results
Page 5 of 8
PRE 14A
at5nq xp8oo9zd
2 Apr 19
Preliminary proxy
4:29pm
8-K
EX-99.1
1a07cg
15 Mar 19
Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
7:00am
POS AM
xbzhd4x0iz6
28 Feb 19
Prospectus update (post-effective amendment)
4:54pm
POSASR
kz384rwfeb1bos3
28 Feb 19
Automatic shelf registration (post-effective amendment)
4:17pm
8-K
EX-99.1
xwbscz c8qnw
28 Feb 19
Karyopharm Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
7:22am
8-K
EX-99.1
uxibwb8i560legbds0x
7 Jan 19
Regulation FD Disclosure
8:26am
8-K
EX-99.1
sv3jemz8831
3 Dec 18
Other Events
4:06pm
8-K
EX-99.2
fomqqshza2j5eytiyfd
3 Dec 18
Other Events
4:06pm
8-K
EX-99.1
0fn9pna757i4xty5
8 Nov 18
Karyopharm Reports Third Quarter 2018 Financial Results and Highlights Recent Company Progress
7:08am
8-K
EX-4.1
6t79 g4ygl7g
16 Oct 18
Entry into a Material Definitive Agreement
4:18pm
8-K
EX-99.1
b76fimybq7e6yprorw
11 Oct 18
Other Events
7:17am
8-K
EX-99.1
sad8 ibkqrtsdj5ufq
9 Oct 18
Karyopharm Therapeutics Announces Proposed Private Offering of $150 Million of
4:10pm
8-K
EX-99.1
dsodmw
9 Oct 18
Other Events
7:00am
424B5
61bpljb wetxc074n
17 Aug 18
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
peh1v0i3 vl50ubj7
7 Aug 18
Karyopharm Reports Second Quarter 2018 Financial Results and Highlights Recent Progress
7:18am
8-K
EX-99.1
xfa6f8
6 Aug 18
Other Events
4:17pm